Literature DB >> 23728404

Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis.

Nina M Patel1, Steven M Kawut, Sanja Jelic, Selim M Arcasoy, David J Lederer, Alain C Borczuk.   

Abstract

A third of patients with idiopathic pulmonary fibrosis (IPF) develop pulmonary hypertension (PH-IPF), which is associated with increased mortality. Whether an altered gene expression profile in the pulmonary vasculature precedes the clinical onset of PH-IPF is unknown. We compared gene expression in the pulmonary vasculature of IPF patients with and without PH with controls. Pulmonary arterioles were isolated using laser capture microdissection from 16 IPF patients: eight with PH (PH-IPF) and eight with no PH (NPH-IPF), and seven controls. Probe was prepared from extracted RNA, and hybridised to Affymetrix Hu133 2.0 Plus genechips. Biometric Research Branch array tools and Ingenuity Pathway Analysis software were used for analysis of the microarray data. Univariate analysis revealed 255 genes that distinguished IPF arterioles from controls (p<0.001). Mediators of vascular smooth muscle and endothelial cell proliferation, Wnt signalling and apoptosis were differentially expressed in IPF arterioles. Unsupervised and supervised clustering analyses revealed similar gene expression in PH-IPF and NPH-IPF arterioles. The pulmonary arteriolar gene expression profile is similar in IPF patients with and without coexistent PH. Pathways involved in vascular proliferation and aberrant apoptosis, which may contribute to pulmonary vascular remodelling, are activated in IPF patients.

Entities:  

Keywords:  DNA microarray; laser capture microdissection; pulmonary arterial hypertension; usual interstitial pneumonia

Mesh:

Year:  2013        PMID: 23728404      PMCID: PMC4720265          DOI: 10.1183/09031936.00084112

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  30 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Abnormal vascular phenotypes in patients with idiopathic pulmonary fibrosis and secondary pulmonary hypertension.

Authors:  James Gagermeier; James Dauber; Samuel Yousem; Kevin Gibson; Naftali Kaminski
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

3.  Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation.

Authors:  M B Marrero; B Schieffer; B Li; J Sun; J B Harp; B N Ling
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

4.  Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells.

Authors:  I Dumler; A Kopmann; K Wagner; O A Mayboroda; U Jerke; R Dietz; H Haller; D C Gulba
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

5.  Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury. Autocrine/paracrine role of endogenous fibroblast growth factor-2.

Authors:  F S Santiago; H C Lowe; Y V Bobryshev; L M Khachigian
Journal:  J Biol Chem       Date:  2001-08-03       Impact factor: 5.157

6.  Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin.

Authors:  Amy K L Banes; Seán M Shaw; Amany Tawfik; Bela P Patel; Safia Ogbi; David Fulton; Mario B Marrero
Journal:  Am J Physiol Cell Physiol       Date:  2004-12-15       Impact factor: 4.249

7.  Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6.

Authors:  Vishal G Warke; Madhusoodana P Nambiar; Sandeep Krishnan; Klaus Tenbrock; David A Geller; Nicolas P Koritschoner; James L Atkins; Donna L Farber; George C Tsokos
Journal:  J Biol Chem       Date:  2003-02-16       Impact factor: 5.157

8.  Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells.

Authors:  I Dumler; A Kopmann; A Weis; O A Mayboroda; K Wagner; D C Gulba; H Haller
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-02       Impact factor: 8.311

9.  Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension.

Authors:  Rosane O D Achcar; Yoshiki Demura; Pradeep R Rai; Laima Taraseviciene-Stewart; Michael Kasper; Norbert F Voelkel; Carlyne D Cool
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

10.  Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells.

Authors:  Mandy Woods; Elizabeth G Wood; Sonya C Bardswell; David Bishop-Bailey; Stewart Barker; Stephen J Wort; Jane A Mitchell; Timothy D Warner
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

View more
  15 in total

1.  ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.

Authors:  Shennea Marriott; Rubin S Baskir; Christa Gaskill; Swapna Menon; Erica J Carrier; Janice Williams; Megha Talati; Karen Helm; Catherine E Alford; Jonathan A Kropski; James Loyd; Lisa Wheeler; Joyce Johnson; Eric Austin; Eva Nozik-Grayck; Barbara Meyrick; James D West; Dwight J Klemm; Susan M Majka
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-15       Impact factor: 4.249

Review 2.  Molecular approach to the classification of chronic fibrosing lung disease-there and back again.

Authors:  Stijn E Verleden; Peter Braubach; Mark Kuehnel; Nicolas Dickgreber; Emily Brouwer; Pauline Tittmann; Florian Laenger; Danny Jonigk
Journal:  Virchows Arch       Date:  2020-11-09       Impact factor: 4.064

3.  Clinical and molecular features of rapidly progressive chronic hypersensitivity pneumonitis.

Authors:  Yasushi Horimasu; Nobuhisa Ishikawa; Hiroshi Iwamoto; Shinichiro Ohshimo; Hironobu Hamada; Noboru Hattori; Morihito Okada; Koji Arihiro; Yuji Ohtsuki; Nobuoki Kohno
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 4.  Group 3 Pulmonary Hypertension: From Bench to Bedside.

Authors:  Navneet Singh; Peter Dorfmüller; Oksana A Shlobin; Corey E Ventetuolo
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

Review 5.  Integrating omics technologies to study pulmonary physiology and pathology at the systems level.

Authors:  Ravi Ramesh Pathak; Vrushank Davé
Journal:  Cell Physiol Biochem       Date:  2014-04-28

6.  A Review of Transcriptome Analysis in Pulmonary Vascular Diseases.

Authors:  Dustin R Fraidenburg; Roberto F Machado
Journal:  Methods Mol Biol       Date:  2018

7.  Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension.

Authors:  James D West; Eric D Austin; Christa Gaskill; Shennea Marriott; Rubin Baskir; Ganna Bilousova; Jyh-Chang Jean; Anna R Hemnes; Swapna Menon; Nathaniel C Bloodworth; Joshua P Fessel; Johnathan A Kropski; David Irwin; Lorraine B Ware; Lisa Wheeler; Charles C Hong; Barbara Meyrick; James E Loyd; Aaron B Bowman; Kevin C Ess; Dwight J Klemm; Pampee P Young; W David Merryman; Darrell Kotton; Susan M Majka
Journal:  Am J Physiol Cell Physiol       Date:  2014-05-28       Impact factor: 4.249

8.  Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis.

Authors:  Riitta Kaarteenaho; Elisa Lappi-Blanco
Journal:  Fibrogenesis Tissue Repair       Date:  2015-03-02

Review 9.  Microarray analysis in pulmonary hypertension.

Authors:  Julia Hoffmann; Jochen Wilhelm; Andrea Olschewski; Grazyna Kwapiszewska
Journal:  Eur Respir J       Date:  2016-04-13       Impact factor: 16.671

10.  Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.

Authors:  Yunguan Wang; Jaswanth Yella; Jing Chen; Francis X McCormack; Satish K Madala; Anil G Jegga
Journal:  BMC Pulm Med       Date:  2017-10-20       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.